ENTRY       D03231                      Drug
NAME        Epoetin alfa (USAN/INN);
            Epoetin kappa (INN);
            Epoetin alfa (genetical recombination) (JP18);
            Epoetin kappa (genetical recombination) [Epoetin alfa biosimilar 1] (JAN);
            Epoetin alfa-epbx;
            Epogen (TN);
            Epoetin alfa BS (TN)
PRODUCT     EPOGEN (Amgen)
            PROCRIT (Janssen Products)
            RETACRIT (Pfizer Laboratories Div Pfizer)
            RETACRIT (Vifor (International))
FORMULA     C809H1301N229O240S5
EXACT_MASS  18224.5242
MOL_WEIGHT  18235.7015
SEQUENCE    APPRLICDSR VLERYLLEAK EAENITTGCA EHCSLNENIT VPDTKVNFYA WKRMEVGQQA
            VEVWQGLALL SEAVLRGQAL LVNSSQPWEP LQLHVDKAVS GLRSLTTLLR ALGAQKEAIS
            PPDAASAAPL RTITADTFRK LFRVYSNFLR GKLKLYTGEA CRTGD
            (Disulfide bridge: 7-161, 29-33)
  TYPE      Peptide
REMARK      Therapeutic category: 3999
            ATC code: B03XA01
            Chemical structure group: DG00177
            Product (DG00177): D03231<JP/US> D03232<JP>
EFFICACY    Anti-anemic, Hematinic, Erythropoietin receptor agonist
  DISEASE   Anemia due to chronic kidney disease [DS:H01642]
TARGET      EPOR [HSA:2057] [KO:K05079]
  PATHWAY   hsa04060(2057)  Cytokine-cytokine receptor interaction
            hsa04630(2057)  JAK-STAT signaling pathway
            hsa04640(2057)  Hematopoietic cell lineage
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B03 ANTIANEMIC PREPARATIONS
               B03X OTHER ANTIANEMIC PREPARATIONS
                B03XA Other antianemic preparations
                 B03XA01 Erythropoietin
                  D03231  Epoetin alfa (USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Blood Products and Modifiers
              Blood Products and Modifiers, Other
               Erythropoietins
                Epoetin Alfa
                 D03231  Epoetin alfa (USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D03231  Epoetin alfa (USAN/INN); Epoetin kappa (INN); Epoetin alfa (genetical recombination) (JP18); Epoetin kappa (genetical recombination) [Epoetin alfa biosimilar 1] (JAN)
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               CSF and other factor receptors
                EPOR
                 D03231  Epoetin alfa (USAN/INN) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D03231  Epoetin alfa (genetical recombination)
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D03231
DBLINKS     CAS: 113427-24-0
            PubChem: 17397384
///
